Trial Profile
Photodynamic Therapy With Photofrin [porfimer sodium] for Treatment of Dysplasia, Carcinoma In Situ and Stage I Carcinoma of the Oral Cavity and the Larynx: A Pilot Study.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.